A new preclinical study in Materials Today Bio describes engineered exosomes designed to steer neural stem cells toward becoming neurons after spinal cord injury. The results in rats are interesting. They are also early, and they say nothing yet about what any exosome...
Patients ask us the same practical questions before they ever ask about science: Is it approved? Will my insurance pay? Can I use my HSA? This FAQ answers those questions plainly. The short version is that no exosome product is FDA-approved, coverage is uncommon, and...
Interest in exosome therapy for avascular necrosis of the hip has grown quickly, and for an understandable reason: avascular necrosis is one of the few orthopedic diagnoses where a patient in their thirties or forties can be told that a hip replacement is probably...
Rhode Island is small enough that a patient in Wayland Square, a patient in Cranston and a patient in East Greenwich are all within twenty minutes of the same specialists. That density is an advantage when you are researching regenerative medicine in Providence,...
Exosome therapy for ACL tears is one of the most searched questions in sports orthopedics right now, and for good reason: the anterior cruciate ligament has almost no capacity to heal on its own, and surgical reconstruction, while effective, still leaves a meaningful...
